Substance P activates human eosinophils

Experimental Dermatology

Volumn 24, Issue 7, 2015, Pages 557-559

  Raap, Mieke ^a   Rüdrich, Urda ^a   Ständer, Sonja ^b   Gehring, Manuela ^a   Kapp, Alexander ^a   Raap, Ulrike ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Aprepitant; Eosinophils; Inflammation; Itch; Substance P

Indexed keywords

DEXAMETHASONE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; SUBSTANCE P;

APOPTOSIS; BLOOD SAMPLING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; NOSE PROVOCATION TEST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; BLOOD; DRUG EFFECTS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; IN VITRO STUDY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

APOPTOSIS; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IN VITRO TECHNIQUES; SUBSTANCE P;

EID: 84931577973     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12717     Document Type: Letter

References (9)

1. O'Connor T M, O'Connell J, O'Brien D I et al. J Cell Physiol 2004: 201: 167-180.
2. Aliakbari J, Sreedharan S P, Turck C W et al. Biochem Biophys Res Commun 1987: 148: 1440-1445.
3. Pennefather J N, Lecci A, Candenas M L et al. Life Sci 2004: 74: 1445-1463.
4. Munoz M, Covenas R. Amino Acids 2014: 46: 1727-1750.
5. Toyoda M, Nakamura M, Makino T et al. Br J Dermatol 2002: 147: 71-79.
6. Pavlovic S, Daniltchenko M, Tobin D J et al. J Invest Dermatol 2008: 128: 434-446.
7. Zhang D, Luo X R, Ye X Q et al. Di Yi Jun Yi Da Xue Xue Bao 2005: 25: 1314-1315.
8. Fajac I, Braunstein G, Ickovic M R et al. Allergy 1995: 50: 970-975.
9. Lampinen M, Carlson M, Hakansson L D et al. Allergy 2004: 59: 793-805.